Epigenetic and redox biomarkers: Novel insights from the MARK-AGE study

Mech Ageing Dev. 2019 Jan:177:128-134. doi: 10.1016/j.mad.2018.06.006. Epub 2018 Jun 30.

Abstract

Ageing is a multifactorial process that affects most, if not all, of the body's tissues and organs and can be defined as the accumulation of physical and psychological changes in a human being over time. The rate of ageing differs between individuals of the same chronological age, meaning that 'biological age' of a person may be different from 'chronological age'. Furthermore, ageing represents a very potent risk factor for diseases and disability in humans. Therefore, establishment of markers of biological ageing is important for preventing age-associated diseases and extending health span. MARK-AGE, a large-scale European study, aimed at identifying a set of biomarkers which, as a combination of parameters with appropriate weighting, would measure biological age better than any marker in isolation. But beyond the identification of useful biomarkers, MARK-AGE provided new insights in age-associated specific cellular processes, such as DNA methylation, oxidative stress and the regulation of zinc homeostasis.

Keywords: Biological age; Biomarkers; Chronological age; DNA damage; DNA methyltransferases; Epigenetics; Europe; Health span; Human ageing; Nutrition; Observational study; Oxidative stress; Peripheral blood mononuclear cells; Ten-eleven translocation family of 5-mC hydroxylases; Vaccination; Zinc homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging / metabolism*
  • Aging / pathology
  • Biomarkers / metabolism
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Europe
  • Humans
  • Multicenter Studies as Topic
  • Oxidative Stress*
  • Zinc / metabolism*

Substances

  • Biomarkers
  • Zinc